Microbiology and ImmunologyMicrobiologyPeer-reviewed journal article
Naturally occurring ZCCHC3 variants modulate antiretroviral activity in cynomolgus macaques
Jacob FadipeiD, Tomotaka Okamura, Shige H. YoshimuraiD, Akatsuki SaitoiD
Abstract
Many mammalian cells restrict viral replication by utilizing various host restriction factors. We recently demonstrated that CCHC-type zinc-finger-containing protein 3 (ZCCHC3) suppresses human immunodeficiency virus type 1 (HIV-1) replication through multiple mechanisms. We also revealed that single-nucleotide polymorphisms (SNPs) in human ZCCHC3 affect its antiviral function; however, whether similar genetic and functional diversity is present in other species remains unknown. In this study, we investigated the genetic and functional diversity of ZCCHC3 in cynomolgus macaques, a critical animal model for HIV-1-related research. Sequencing analysis of eight independent ZCCHC3 clones per animal revealed substantial amino acid diversity among cynomolgus macaques. We selected 12 representative variants and examined their antiviral activity against several retroviral vectors derived from HIV-1, simian immunodeficiency virus, feline immunodeficiency virus, and murine leukemia virus. Moreover, using replication-competent HIV-1, we showed that selected cynomolgus macaque ZCCHC3 variants can affect both viral production and viral infectivity. These results suggest that the genetic and functional diversity of ZCCHC3 is not limited to humans and underscore the importance of considering ZCCHC3 variation in cynomolgus macaques when using them as animal models for HIV-1-related research.
- organism: chicken / avian
- research focus: host-pathogen & immune response
- approach: experimental assay
- Citations
- 0
- FWCI
- 0.00
- Field percentile
- 33th percentile
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Host ZCCHC3 blocks HIV-1 infection and production by a dual mechanism
B. Yi, Y. L. Tanaka, … S. H. Yoshimura·bioRxiv·Jun 14, 2023
- Loop 1 of APOBEC3C regulates its antiviral activity against HIV-1
A. A. Jaguva Vasudevan, K. Balakrishnan, … C. Münk·bioRxiv·Feb 5, 2020
- Recurrent Emergence of an Antiviral Defense through Repeated Retrotransposition and Truncation of CHMP3
L. Rheinemann, D. M. Downhour, … N. C. Elde·bioRxiv·Apr 27, 2021
- APOBEC3G Splicing Defects in Nonhuman Primate Models Result in Disparate Viral Mutational Profiles Relative to Humans
Armando D. Mendez, Rachael Springman-Rodriguez, … Diako Ebrahimi·bioRxiv·Aug 12, 2026
- Divergence in dimerization and activity of primate APOBEC3C
A. Gaba, M. A. Hix, … L. Chelico·bioRxiv·Jul 13, 2021
- Impact of suboptimal APOBEC3G neutralization on the emergence of HIV drug resistance in humanized mice
M. M. Hernandez, A. Fahrny, … V. Simon·bioRxiv·Sep 11, 2019